Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 314 for infectious diseases

Edit search filters
  1. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection

    Rochester, MN

  2. A Study to Compare Saliva and Swab Specimens in Detection of COVID Severe Acute Respiratory Syndrome

    Rochester, MN

  3. Study to Evaluate the Effectiveness and Safety of Remdesivir in Participants with Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019

    Jacksonville, FL, Rochester, MN

  4. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection

    Rochester, MN

  6. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19

    Jacksonville, FL, Rochester, MN

  7. Acupuncture Therapy for COVID-Related Olfactory Loss

    Rochester, MN

  8. SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)

    Rochester, MN

  9. Immunological Consequences of COVID-19 Vaccination in Patients with Rheumatic Diseases

    Rochester, MN

  10. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection

    Rochester, MN

.

Mayo Clinic Footer